期刊文献+

IL-21上调IL-17的表达在Graves病中的意义 被引量:5

Significance of IL-17 upregulation by IL-21 in patients with Graves disease
下载PDF
导出
摘要 目的探讨IL-21上调IL-17表达在Graves病(GD)中的意义。方法收集30例初发GD患者、17例经药物治疗后甲状腺功能恢复正常的GD(eGD)患者和18例健康对照者,采用电化学发光法检测患者的甲状腺功能指标(FT3、FT4和uTSH)和自身抗体(TgAb、TPOAb和TRAb)水平。采集研究对象的外周血并分离单个核淋巴细胞(PBMCs),设IL-21刺激组和IL-21未刺激组。体外培养PBMCs后,ELISA法检测细胞上清液中IL-17蛋白的表达;半定量RT-PCR法检测IL-17和RORγt mRNA的表达。结果 GD组的甲状腺功能指标与正常对照组eGD组比较,差异均有统计学意义(P<0.05);但eGD组与正常对照组比较差异无统计学意义(P>0.05)。GD组和eGD组的自身抗体水平均显著高于正常对照组,差异有统计学意义(P<0.05);但GD组与eGD组比较差异无统计学意义(P>0.05)。IL-21刺激前,GD组、eGD组的IL-17 mRNA、RORγt mRNA和IL-17蛋白表达水平均较正常对照组明显升高,差异有统计学意义(P<0.05),但GD组与eGD组比较差异无统计学意义(P>0.05)。经IL-21刺激后,GD组、eGD组和正常对照组的IL-17 mRNA、RORγt mRNA和IL-17蛋白的表达水平均显著高于刺激前,且GD组和eGD组显著高于正常对照组,差异均有统计学意义(P<0.05);但GD组与eGD组间比较差异无统计学意义(P>0.05)。结论 IL-21通过上调IL-17的表达参与了GD的发病机制,且这一机制可能并不依赖于甲状腺功能,而与自身免疫过程相关。 Objective To analyze the role of IL-21 in IL-17 upregulation of patients with Graves disease (GD). Methods Thirty patients with GD were enrolled as GD group; 17 patients with euthyroid GD after treatment, as eGD group; and 18 healthy subjects, as control group. Electrochemical luminescence detection was used to determine levels of thyroid function indexes (FT3, FT4, and uTSH) and autoantibodies (TgAb, TPOAb, and TRAb). The peripheral blood mononuclear cells (PBMCs) were cultured in the presence or absence of IL-21 in vitro. The level of IL-17 protein was measured by enzyme- linked immunosorbent assay (ELISA), and expressions of IL-17 and ROR',/t mRNA were examined by semi-quantitative RT-PCR. Results Compared to control and eGD groups, there were significantly differences in the levels of thyroid function indexes in GD group (P 〈 0.05), whereas there was no difference between control group and eGD group (P 〉 O. 05). Before IL-12 stimulation, compared to control group, expressions of IL-17 and ROR"yt mRNA and level of IL-17 protein were significantly higher in GD and eGD groups ( P 〈 0.05) ; but there were no significant differences between GD group and eGD group (P 〉 0.05). After IL-12 stimulation, expressions of IL-17 and ROR~/t mRNA and IL-17 protein levels markedly increased in all three groups, which were significantly higher in GD and eGD groups compared to control group (P 〈 0. 05). There were no differences of the values between GD group and eGD group (P 〉 0. 05). Conclusion The results indicated that IL-21 involved in the pathogenesis of GD through IL-17 upregulation, which might be not dependent on thyroid function but be related to autoimmunity.
作者 卢永霞 刘纯
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第1期65-69,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 IL-21 IL-17 GRAVES病 免疫 IL-21 IL-17 Graves disease immunity
  • 相关文献

参考文献16

  • 1Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17 producing helper T cells [J]. Nat lmmunol, 2007, 8(9) : 950 -957.
  • 2Zheng L, Ye P, Liu C. The role of the IL-23/IL-17 axis in the pathogenesis of Graves' disease[J]. Endocr J, 2013, 60(5) : 591 - 597.
  • 3Bossowski A, Moniuszko M, Idzkowska E, et al. Evaluation of CD4+ CD161 + CD196 + and CD4 + IL-17+ Th17 cells in the peri- pheral blood of young patients with Hashimoto's thyroiditis and Graves' disease[ J]. Pediatr Endocfinol Diabetes Metab, 2012, 18 (3) : 89 -95.
  • 4Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cell[J]. Cell, 2006, 126(6) : 1121 -33.
  • 5Vogelzang A, McGuire HM, Yu D, et al. A fundamental role for interleukin-21 in the generation of T follicular helper cells[J]. Immunity, 2008, 29( 1 ) : 127 - 137.
  • 6Zhou L, Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways[J]. Nat Immunol, 2007, 8(9) : 967 -974.
  • 7Attfidge K, Wang C J, Wardzinski L, et al. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis [ J ]. Blood, 2012, 119 (20) : 4656 -4664.
  • 8陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2010:282.
  • 9Glick AB, Wodzinski A, Fu P, et al. Impairment of regulatory T cell function in autoimmune thyroid disease[ J]. Thyroid, 2013, 23 (7) : 871 -878.
  • 10Jia HY, Zhang ZG, Gu X J, et al. Association between interleukin 21 and Graves' disease[J]. Genet Mol Res, 2011, 10(4) : 3338 - 3346.

共引文献272

同被引文献39

  • 1洪琼,徐建华,徐胜前,等.类风湿关节炎患者血清IL-17和IL-23水平变化及其临床意义[J].中华临床医师杂志(电子版),2013,7(2):621-625.
  • 2Sehmsdorf US,Zenclussen AC,Arck P,et al.Human mis- carriage is associated with increased number of CD26 de cidual lymphocytes[J].Scand J Immunol,2004,59(4):400-407.
  • 3Arasteh J,Pourpak Z,Ebtekar M,et al.Evaluation of the effect of IL-22 on human cord blood CD4+ T cellsp[J].I- ran J Allergy Asthma Immunol,2010,9(2):59-67.
  • 4Jiang R,Wang H,Deng L,et al.IL-22 is related to devel- opment of human colon cancer by activation of STAT3[J].BMC Cancer,2013,13:59.
  • 5Zhuang Y,Peng LS,Zhao YL,et al.Increased intratu- moral IL-22-producing CD4(+)T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival[J].Cancer Immunol Immunother,2012,61(11):1965-1975.
  • 6Jiang R,Tan Z,Deng L,et al.Interleukin-22 promotes hu- man hepatocellular carcinoma by activation of STAT3[J].Hepatology,2011,54(3):900-909.
  • 7Liu Y,Wang J,Zhang X.Accurate determination of the vapor-liquid-solid contact line tension and the viability of Young equation[J].Sci Rep,2013,3;2008.
  • 8Yeste A,Mascanfroni ID,Nadeau M,et al.IL-21 induces IL-22 production in CD4+ T cells[J].Nat Commun,2014,5:3753.
  • 9Rutz S,Noubade R,Eidenschenk C,et al.Transcription factor c-Maf mediates the TGF-beta-dependent sup- pression of IL-22 production in T(H)17cells[J].INat Im- munol,2011,12(12);1236-1238.
  • 10徐雪,吕玲.白细胞介素-17与类风湿关节炎[J].中华风湿病学杂志,2008,12(10):719-721. 被引量:14

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部